Galectin Therapeutics Statistics
Total Valuation
GALT has a market cap or net worth of $150.40 million. The enterprise value is $209.31 million.
| Market Cap | 150.40M |
| Enterprise Value | 209.31M |
Important Dates
The next estimated earnings date is Monday, August 12, 2024, before market open.
| Earnings Date | Aug 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
GALT has 62.15 million shares outstanding. The number of shares has increased by 4.20% in one year.
| Shares Outstanding | 62.15M |
| Shares Change (YoY) | +4.20% |
| Shares Change (QoQ) | +0.18% |
| Owned by Insiders (%) | 31.01% |
| Owned by Institutions (%) | 12.28% |
| Float | 42.97M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.02
| Current Ratio | 2.02 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -12.19 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -185.90% |
| Return on Capital (ROIC) | -387.18% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.20M |
| Employee Count | 14 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +41.52% in the last 52 weeks. The beta is 0.64, so GALT's price volatility has been lower than the market average.
| Beta (5Y) | 0.64 |
| 52-Week Price Change | +41.52% |
| 50-Day Moving Average | 2.63 |
| 200-Day Moving Average | 2.30 |
| Relative Strength Index (RSI) | 49.07 |
| Average Volume (20 Days) | 293,828 |
Short Selling Information
The latest short interest is 4.01 million, so 6.45% of the outstanding shares have been sold short.
| Short Interest | 4.01M |
| Short Previous Month | 3.95M |
| Short % of Shares Out | 6.45% |
| Short % of Float | 9.33% |
| Short Ratio (days to cover) | 16.74 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -37.38M |
| Pretax Income | -44.65M |
| Net Income | -44.78M |
| EBITDA | -41.25M |
| EBIT | -41.26M |
| Earnings Per Share (EPS) | -$0.74 |
Balance Sheet
The company has $23.56 million in cash and $82.46 million in debt, giving a net cash position of -$58.91 million or -$0.95 per share.
| Cash & Cash Equivalents | 23.56M |
| Total Debt | 82.46M |
| Net Cash | -58.91M |
| Net Cash Per Share | -$0.95 |
| Equity (Book Value) | -72.81M |
| Book Value Per Share | -1.17 |
| Working Capital | 12.83M |
Cash Flow
| Operating Cash Flow | -34.28M |
| Capital Expenditures | n/a |
| Free Cash Flow | -34.28M |
| FCF Per Share | -$0.55 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
GALT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.20% |
| Shareholder Yield | -4.20% |
| Earnings Yield | -29.77% |
| FCF Yield | -22.79% |
Analyst Forecast
The average price target for GALT is $11.00, which is 354.55% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $11.00 |
| Price Target Difference | 354.55% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on March 23, 2012. It was a reverse split with a ratio of 1:6.
| Last Split Date | Mar 23, 2012 |
| Split Type | Reverse |
| Split Ratio | 1:6 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |